Boston Scientific hopes to strengthen its foothold in the cardiac rhythm management market with the acquisition of Cameron Health, maker of the S-ICD wireless defibrillator. The deal calls for Boston Scientific to pay $150 million upfront in cash and possibly $150 million more upon FDA approval of the S-ICD system, plus as much as $1.05 billion in potential milestone payments during the course of the six years immediately after FDA approval.

Related Summaries